Skin aging is increasingly recognized as a process associated with the microbiome, characterized by barrier dysfunction, chronic low-grade inflammation, and degradation of the extracellular matrix. Current evidence suggests that age-related changes in both skin and gut microbiota contribute to "inflammaging" and impaired cutaneous homeostasis through the gut-skin axis. In recent years, probiotics, prebiotics, and postbiotics have emerged as potential modulators of skin aging. Probiotics, in particular, are noted for their ability to modulate the gut-skin axis, decrease inflammation, and promote skin rejuvenation. In this discussion, we highlight current evidence on the role of probiotic-based interventions in skin aging and geriatric dermatoses. Probiotics, prebiotics, and postbiotics modulate skin aging by restoring microbial balance, enhancing barrier integrity, and regulating immune and oxidative pathways, particularly through the gut-skin axis. Topical formulations act locally by reinforcing tight junctions, increasing ceramide synthesis, and suppressing inflammatory mediators and matrix metalloproteinases, whereas oral probiotics exert their effects by modulating gut dysbiosis, reducing systemic inflammation, and improving extracellular matrix homeostasis. Clinical studies have shown improvements in skin hydration, elasticity, wrinkle depth, photoprotection, and wound healing. Although there have been promising results, several challenges remain about strain specificity, formulation stability, regulatory constraints on viable organisms, and the paucity of powered randomized clinical trials. Overall, microbiome-targeted interventions hold promise as a strategy for reducing age-related skin changes and managing skin conditions in the elderly.
